Security Agreements in the Biotechnology Industry
290 Contracts & Agreements
- ABEONA THERAPEUTICS INC. (1 contract)
- Achaogen, Inc. (2)
- Acorda Therapeutics (1)
- Adaptimmune Therapeutics PLC (2)
- Adhera Therapeutics, Inc. (15)
- ADiTx Therapeutics, Inc. (12)
- ADMA BIOLOGICS, INC. (3)
- Advaxis, Inc. (5)
- AGENUS INC (2)
- AgeX Therapeutics, Inc. (2)
- Akebia Therapeutics, Inc. (1)
- Aldeyra Therapeutics, Inc. (2)
- Alexion Pharmaceuticals (1)
- Allarity Therapeutics, Inc. (2)
- Alliqua BioMedical, Inc. (1)
- ALNYLAM PHARMACEUTICALS, INC. (1)
- AMARILLO BIOSCIENCES INC (1)
- APPLIED GENETIC TECHNOLOGIES CORP (1)
- Aptevo Therapeutics Inc. (1)
- AquaBounty Technologies, Inc. (3)
- AQUINOX PHARMACEUTICALS, INC (2)
- Arcturus Therapeutics Holdings Inc. (1)
- ARENA PHARMACEUTICALS INC (1)
- Aridis Pharmaceuticals, Inc. (2)
- ARROWHEAD PHARMACEUTICALS, INC. (1)
- Athenex, Inc. (2)
- AVEO PHARMACEUTICALS INC (3)
- Avid Bioservices, Inc. (4)
- Avita Therapeutics, Inc. (1)
- AzurRx BioPharma, Inc. (2)
- BioCardia, Inc. (2)
- BIOCEPT INC (1)
- BioRestorative Therapies, Inc. (2)
- Biostage, Inc. (3)
- BIOTIME INC (4)
- BIOXYTRAN, INC (2)
- BRAINSTORM CELL THERAPEUTICS INC. (1)
- CALADRIUS BIOSCIENCES, INC. (1)
- CANCER GENETICS, INC (3)
- CAPRICOR THERAPEUTICS, INC. (1)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (3)
- CareDx, Inc. (1)
- Caribou Biosciences, Inc. (1)
- CASI Pharmaceuticals, Inc. (1)
- Celldex Therapeutics, Inc. (1)
- Cellectar Biosciences, Inc. (1)
- Chanticleer Holdings, Inc. (2)
- Chelsea Worldwide Inc. (1)
- Cibus Global, Ltd. (2)
- Clovis Oncology, Inc. (2)
- CTD HOLDINGS INC (2)
- CTI BIOPHARMA CORP (3)
- Curative Biotechnology Inc (6)
- CURIS INC (4)
- Cyclacel Pharmaceuticals, Inc. (3)
- CytoDyn Inc. (6)
- CYTORI THERAPEUTICS, INC. (1)
- Diffusion Pharmaceuticals Inc. (2)
- Digital Development Partners, Inc. (1)
- DYADIC INTERNATIONAL INC (1)
- Emerald Bioscience, Inc. (1)
- ENDONOVO THERAPEUTICS, INC. (3)
- Enochian Biosciences Inc (1)
- Flexion Therapeutics Inc (1)
- FLUOROPHARMA MEDICAL, INC. (1)
- Fortress Biotech, Inc. (2)
- GALECTIN THERAPEUTICS INC (1)
- Gene Biotherapeutics, Inc. (2)
- GENEREX BIOTECHNOLOGY CORP (3)
- Genprex, Inc. (1)
- GeoVax Labs, Inc. (2)
- GT Biopharma, Inc. (2)
- HALOZYME THERAPEUTICS INC (1)
- HedgePath Pharmaceuticals, Inc. (1)
- HEMISPHERX BIOPHARMA INC (5)
- HERON THERAPEUTICS, INC. (2)
- HUMANIGEN, INC (2)
- iBio, Inc. (2)
- IDERA PHARMACEUTICALS, INC. (2)
- IMMUNE PHARMACEUTICALS INC (1)
- INFINITY PHARMACEUTICALS, INC. (3)
- Innovation Pharmaceuticals Inc. (1)
- INTERCEPT PHARMACEUTICALS, INC. (1)
- International Stem Cell CORP (2)
- INTREXON CORP (3)
- Intrinsic Medicine, Inc. (1)
- IRONWOOD PHARMACEUTICALS INC (1)
- Isoray, Inc. (1)
- Leisure Acquisition Corp. (9)
- Locust Walk Acquisition Corp. (2)
- MARIZYME INC (4)
- Marker Therapeutics, Inc. (3)
- Medovex Corp. (5)
- MiMedx Group, Inc. (4)
- NantKwest, Inc. (1)
- NAVIDEA BIOPHARMACEUTICALS, INC. (5)
- NEUROBIOLOGICAL TECHNOLOGIES INC (2)
- NORTHWEST BIOTHERAPEUTICS INC (1)
- NOVAVAX INC (2)
- Novus Therapeutics, Inc. (1)
- NTN BUZZTIME INC (2)
- Nuo Therapeutics, Inc. (3)
- OncBioMune Pharmaceuticals, Inc (7)
- OPGEN INC (1)
- ORAGENICS INC (2)
- Organicell Regenerative Medicine, Inc. (2)
- Outlook Therapeutics, Inc. (1)
- Pfenex Inc. (1)
- PhaseBio Pharmaceuticals Inc (1)
- PROGENITY, INC. (1)
- Propanc Biopharma, Inc. (1)
- Protagenic Therapeutics, Inc. (2)
- Protalix BioTherapeutics, Inc. (1)
- PTC THERAPEUTICS, INC. (2)
- Q BioMed Inc. (1)
- Retrophin, Inc. (1)
- Rich Pharmaceuticals, Inc. (1)
- SELLAS Life Sciences Group, Inc. (1)
- Shuttle Pharmaceuticals Holdings, Inc. (2)
- SOPHIRIS BIO INC. (2)
- Spero Therapeutics, Inc. (1)
- SPHERIX INC (1)
- SUNESIS PHARMACEUTICALS INC (1)
- Synthetic Biologics, Inc. (1)
- T2 Biosystems, Inc. (1)
- TG THERAPEUTICS, INC. (1)
- Tonix Pharmaceuticals Holding Corp. (1)
- United Therapeutics Corp (2)
- VACCINEX, INC. (2)
- VBI Vaccines Inc (1)
- Vertex Pharmaceuticals Inc (1)
- VICAL INC (2)
- VistaGen Therapeutics, Inc. (2)
- VITRO DIAGNOSTICS INC (1)
- WINDTREE THERAPEUTICS INC (4)
- Xenetic Biosciences, Inc. (3)
- Security and Pledge Agreement as of December 29, 2023 among ImmunityBio, Inc., the Subsidiary Guarantors listed on the signature pages hereto, such other parties that may become... (NantKwest, Inc., Filed With SEC on March 19, 2024)
- Form of Shareholder Security Agreement (AzurRx BioPharma, Inc., Filed With SEC on March 14, 2024)
- Security Agreement, dated as of October 3, 2022, by and between ImmunogenX and Mattress Liquidators, Inc (AzurRx BioPharma, Inc., Filed With SEC on March 14, 2024)
- Security Agreement (DYADIC INTERNATIONAL INC, Filed With SEC on March 11, 2024)
- Trademark Security Agreement (Avita Therapeutics, Inc., Filed With SEC on February 22, 2024)
- Form of Security Agreement, to be dated as of the Closing Date, between the Company, as issuer, subsidiaries of the Company, as guarantors, and GLAS Trust Company LLC, as... (PROGENITY, INC., Filed With SEC on December 18, 2023)
- Security Agreement dated December 11, 2023 (ADiTx Therapeutics, Inc., Filed With SEC on December 12, 2023)
- IP Security Agreement dated December 11, 2023 (ADiTx Therapeutics, Inc., Filed With SEC on December 12, 2023)
- Second Amendment to Security Agreement dated as of November 27, 2023 between Navidea Biopharmaceuticals, Inc. and John Kim Scott, Jr (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on December 1, 2023)
- Security Agreement (VITRO DIAGNOSTICS INC, Filed With SEC on November 22, 2023)
- Form of Patent Security Agreement, to be entered into by and among the Company, EBI OpCo, Inc., EBI, Inc. and the other parties signatory thereto (Leisure Acquisition Corp., Filed With SEC on October 24, 2023)
- Form of Security Agreement to be entered into by and among the Company, EBI OpCo, Inc., EBI, Inc. and the other parties signatory thereto (Leisure Acquisition Corp., Filed With SEC on October 24, 2023)
- Security Agreement, dated as of September 28, 2023, by and between Lind Global Fund II LP and Ainos, Inc (AMARILLO BIOSCIENCES INC, Filed With SEC on September 29, 2023)
- Amended and Restated Security Agreement (OncBioMune Pharmaceuticals, Inc, Filed With SEC on August 21, 2023)
- Security Agreement, dated August 7, 2023, by and between Ayala Pharmaceuticals, Inc. and Israel Biotech Fund I, L.P (Advaxis, Inc., Filed With SEC on August 10, 2023)
- SECURITY AGREEMENT (SECURITIES ACCOUNT) (Arcturus Therapeutics Holdings Inc., Filed With SEC on August 7, 2023)
- Form of Security Agreement (ADiTx Therapeutics, Inc., Filed With SEC on July 28, 2023)
- Security Agreement, dated as of July 11, 2023, by and between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P (IDERA PHARMACEUTICALS, INC., Filed With SEC on July 11, 2023)
- Form of Security Agreement (ADiTx Therapeutics, Inc., Filed With SEC on July 7, 2023)
- Security Agreement (Allarity Therapeutics, Inc., Filed With SEC on June 30, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on June 29, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on May 5, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on May 4, 2023)
- Security Agreement dated as of April 26, 2023 (Aridis Pharmaceuticals, Inc., Filed With SEC on May 1, 2023)
- First Amendment to Security Agreement dated as of April 25, 2023 between Navidea Biopharmaceuticals, Inc. and John Kim Scott, Jr (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- First Amendment to Security Agreement (Allarity Therapeutics, Inc., Filed With SEC on April 12, 2023)
- Amended and Restated Security Agreement, dated March 13, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited (AgeX Therapeutics, Inc., Filed With SEC on March 15, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on March 8, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on February 23, 2023)
- Trademark Security Agreement, dated February 21, 2023, by and among Gelesis Holdings, Inc., Gelesis, Inc., Gelesis 2012, Inc., Gelesis LLC and PureTech Health LLC (CAPSTAR SPECIAL PURPOSE ACQUISITION CORP., Filed With SEC on February 23, 2023)
- Patent Security Agreement, dated February 21, 2023, by and among Gelesis Holdings, Inc., Gelesis, Inc., Gelesis 2012, Inc., Gelesis LLC and PureTech Health LLC (CAPSTAR SPECIAL PURPOSE ACQUISITION CORP., Filed With SEC on February 23, 2023)
- Security and Pledge Agreement, dated February 21, 2023, by and among Gelesis Holdings, Inc., Gelesis, Inc., Gelesis 2012, Inc., Gelesis LLC and PureTech Health LLC (CAPSTAR SPECIAL PURPOSE ACQUISITION CORP., Filed With SEC on February 23, 2023)
- Security Agreement (Enochian Biosciences Inc, Filed With SEC on February 23, 2023)
- Form of Contingent Subsidiary Security (Fortress Biotech, Inc., Filed With SEC on February 9, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on January 26, 2023)
- Form of Intellectual Property Security Agreement (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on January 12, 2023)
- Form of Security Agreement (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on January 12, 2023)
- Pledge and Security Agreement, dated as of January 6, 2023, by and among the Company certain subsidiaries of the Company, as grantors, and the Administrative Agent (Clovis Oncology, Inc., Filed With SEC on January 12, 2023)
- Form of Security Agreement (OncBioMune Pharmaceuticals, Inc, Filed With SEC on December 1, 2022)
- Security Agreement between Registrant and Mast Hill Fund, L.P (Digital Development Partners, Inc., Filed With SEC on November 14, 2022)
